Idbiologics

Developer of antibodies to treat infectious diseases

placeNashville, Tennessee, United States calendar_todayFounded 2017 groups1 employees language idbiologics.com

Registered entities

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon